Inhibition Transcranial Random Noise Stimulation

Overview

Inhibition control deficits is a major risk factor in the transition to the act in suicidal patients. Neuroimaging studies have shown that this failure was associated with hypoactivity in the prefrontal cortex (PFC), a brain area involved in the control of impulsivity. It was recently shown that a noninvasive brain stimulation session applied on the PFC reduces transiently impulsivity in healthy volunteers. Noninvasive brain stimulation modulates the activity and connectivity of neural network connected to the stimulation site. The investigators assume that a repetition of noninvasive brain stimulation sessions on the PFC will allow a more intense and longer lasting effect on impulsivity and cognitive control in healthy volunteers compared to a single session and to placebo stimulation. The investigators assume that this behavioral change will be accompanied by a change in brain activity measured by resting EEG for the patients in the active group. A more intense and longer lasting effect is an essential step to transfer these results to patient populations. The main objective is to study the effect of bilateral stimulation of the PFC by transcranial random noise stimulation (tRNS) on the inhibition control measured by the cognitive motor inhibition capacity (Go NoGo test). The secondary objectives are to study the effect of tRNS on verbal inhibition (measured with the Hayling test); on anxiety (measured with the State-trait anxiety inventory (STAI)),on angry (measured with the State-trait anger expression inventory (STAXI)) on verbal and nonverbal inhibition (measured by the Stroop test), on impulsive behavior (measured by the Barrat impulsiveness scale (BIS 10)) and on the neuronal electrical activity measured by EEG.

Full Title of Study: “Inhibition Control Modulation by Transcranial Random Noise Stimulation (tRNS ) on the Prefrontal Cortex Measured by Change in Go no Test”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Triple (Participant, Care Provider, Investigator)
  • Study Primary Completion Date: September 29, 2016

Detailed Description

Subjects are stimulated 3 times in a day. Each 20 minutes stimulation are separated by a period of at least 30 minutes. Before and after each stimulation, inhibition is evaluated by cognitive tests (Go Nogo test, Stroop test, Hayling test) and by the BIS 10 scale. During the stimulation, subjects compleat the STAXI and STAI scales. Cognitive tests are repeated 24 hours and 8 days after the stimulation to evaluate duration of the effect. Possible side effects will be notified throughout the protocol.

Interventions

  • Device: transcranial random noise stimulation (tRNS) (Starstim)
    • subjects are stimulated 3 times in a day by transcranial random noise stimulation (tRNS) (Starstim). each 20 minutes stimulation are separated by a period of at least 30 minutes. before and after each stimulation, inhibition is evaluated by cognitive tests: go nogo test, stroop test, Hayling test and by the BIS 10 scale. During the stimulation, subjects compleat the STAXI and STAI scales. Cognitive tests are repeated 24 hours and 8 days after the stimulation to evaluate duration of the effect. Possible side effects will be notified throughout the protocol.

Arms, Groups and Cohorts

  • Sham Comparator: Sham transcranial noise stimulation
    • subjects are stimulated 3 times with sham transcranial random noise stimulation (tRNS) (Starstim) with a 30 seconds offset
  • Active Comparator: 1 Active transcranial random noise stimulation
    • subjects are stimulated 1 time with active transcranial random noise stimulation (tRNS) (Starstim) at 2mA with a oscillatory frequency between 100 and 500 Hz during 20 minutes and 2 times with sham tRNS
  • Active Comparator: 3 Active transcranial random noise stimulation
    • subjects are stimulated 3 times with active transcranial random noise stimulation (tRNS) (Starstim) at 2mA with a oscillatory frequency between 100 and 500 Hz during 20 minutes

Clinical Trial Outcome Measures

Primary Measures

  • Change in go no go test
    • Time Frame: 15 minutes after the stimulation
    • errors and reaction times

Secondary Measures

  • Change in Stroop test
    • Time Frame: 15 minutes after the stimulation
    • errors and reaction times
  • Change in Hayling test
    • Time Frame: 15 minutes after the stimulation
    • errors and reaction times
  • Change in BIS 10
    • Time Frame: 24 hours and 8 days after stimulations
    • motor impulsivity, cognitive impulsivity, non planning impulsivity
  • Change in STAXI
    • Time Frame: 24 hours and 8 days after stimulations
    • score
  • Change in STAI
    • Time Frame: 24 hours and 8 days after stimulations
    • score
  • Change in EEG
    • Time Frame: 24 hours and 8 days after stimulations
  • occurrence of adverse effects
    • Time Frame: 8 days after stimulations

Participating in This Clinical Trial

Inclusion Criteria

  • age between 18 and 45 years Exclusion Criteria:

  • inability to give consent – Under 18 years – over 45 years – pregnant women – nursing mothers – History of neurological or psychiatric disorders and personality disorders in Cluster impulsivity (cluster B) according to Diagnostic and Statistical Manual (DSM) IV – french National Adult Reading Test (fNART): score below the 5th percentile – Contraindications to the practice of transcranial brain stimulation as international safety recommendations (Rossi et al., 2009) – Processing or recent psychotropic

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Hôpital le Vinatier
  • Provider of Information About this Clinical Study
    • Principal Investigator: HAESEBAERT, MD PhD – Hôpital le Vinatier
  • Overall Official(s)
    • HAESEBAERT Frederic, MD PhD, Principal Investigator, HOPITAL VINATIER

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.